Pharvaris N.V.(PHVS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PHVS Pharvaris N.V.

盘前交易 12-23 09:12:01 EST

19.57

+0.56

+2.95%

最高20.48	最低18.77	成交量9.71万
今开19.00	昨收19.01	日振幅9.00%
总市值10.61亿	流通市值3.71亿	总股本5,423万
成交额191.87万	换手率0.51%	流通股本1,898万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"PHVS","market":"US","secType":"STK","nameCN":"Pharvaris N.V.","latestPrice":19.57,"timestamp":1734728400000,"preClose":19.01,"halted":0,"volume":97070,"delay":0,"floatShares":18978273,"shares":54233105,"eps":-2.863788,"marketStatus":"盘前交易","marketStatusCode":1,"change":0.56,"latestTime":"12-23 09:12:01 EST","open":19,"high":20.48,"low":18.77,"amount":1918681.7372,"amplitude":0.089953,"askPrice":30.13,"askSize":5,"bidPrice":14.19,"bidSize":30,"shortable":3,"etf":0,"ttmEps":-2.863788,"exchange":"NASDAQ","tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1734964200000},"adr":0,"listingDate":1612501200000,"adjPreClose":19.57,"postHourTrading":{"tag":"盘后","latestPrice":19.57,"preClose":19.57,"latestTime":"16:01 EST","volume":380,"amount":7436.6,"timestamp":1734728511277},"volumeRatio":1.9792592636743784},"requestUrl":"/m/hq/s/PHVS","defaultTab":"news","newsList":[{"id":"2493885429","title":"Pharvaris N.V.盘中异动 临近午盘股价大涨5.63%报20.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493885429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493885429?lang=zh_cn&edition=full","pubTime":"2024-12-21 00:52","pubTimestamp":1734713555,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日00时52分，Pharvaris N.V.股票出现波动，股价快速上涨5.63%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为0.37%。Pharvaris N.V.公司简介：Pharvaris NV是一家后期阶段的生物制药公司，开发新型口服缓激肽B2受体拮抗剂，以预防和治疗遗传性血管性水肿症发作。Pharvaris目前正在进行一项治疗遗传性血管性水肿症发作的关键 3 期研究，并计划启动一项deucrictibant预防遗传性血管性水肿症发作的关键 3 期研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005235984cfe9d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221005235984cfe9d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2491372977","title":"Pharvaris N.V.盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491372977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491372977?lang=zh_cn&edition=full","pubTime":"2024-12-14 00:11","pubTimestamp":1734106268,"startTime":"0","endTime":"0","summary":"北京时间2024年12月14日00时11分，Pharvaris N.V.股票出现异动，股价急速跳水5.10%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.44%。Pharvaris N.V.公司简介：Pharvaris NV是一家后期阶段的生物制药公司，开发新型口服缓激肽B2受体拮抗剂，以预防和治疗遗传性血管性水肿症发作。Pharvaris目前正在进行一项治疗遗传性血管性水肿症发作的关键 3 期研究，并计划启动一项deucrictibant预防遗传性血管性水肿症发作的关键 3 期研究。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214001108984bdb63&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241214001108984bdb63&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2490837898","title":"Pharvaris N.V.盘中异动 急速上涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490837898","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490837898?lang=zh_cn&edition=full","pubTime":"2024-12-12 01:03","pubTimestamp":1733936593,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日01时03分，Pharvaris N.V.股票出现异动，股价急速上涨5.08%。截至发稿，该股报19.23美元/股，成交量3.6088万股，换手率0.07%，振幅5.19%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.44%。其相关个股中，Protagenic Therapeutics Inc C/Wts 29/04/2026 、Candel Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Silexion Therapeutics Corp、Candel Therapeutics, Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为444.15%、207.41%、109.30%，振幅较大的相关个股有Candel Therapeutics, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Biora Therapeutics, Inc.，振幅分别为160.30%、127.38%、69.68%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121201031395e8fe45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121201031395e8fe45&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2489467418","title":"Pharvaris N.V.盘中异动 快速下跌5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2489467418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489467418?lang=zh_cn&edition=full","pubTime":"2024-12-06 01:05","pubTimestamp":1733418343,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日01时05分，Pharvaris N.V.股票出现异动，股价大幅下跌5.20%。截至发稿，该股报18.96美元/股，成交量7.6968万股，换手率0.14%，振幅8.70%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Protara Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Molecular Templates, Inc.涨幅较大，Molecular Templates, Inc.、Psyence Biomedical Ltd.、Protara Therapeutics, Inc.较为活跃，换手率分别为3281.22%、2318.65%、458.37%，振幅较大的相关个股有Molecular Templates, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Protara Therapeutics, Inc.，振幅分别为124.83%、120.00%、106.21%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120601054398e5a4fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120601054398e5a4fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2488946648","title":"Pharvaris N.V.盘中异动 早盘快速上涨6.63%报20.42美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488946648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488946648?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:37","pubTimestamp":1733236637,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时37分，Pharvaris N.V.股票出现异动，股价快速上涨6.63%。截至发稿，该股报20.42美元/股，成交量3439股，换手率0.01%，振幅10.76%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.23%。其相关个股中，Janux Therapeutics, Inc.、Coherus Biosciences, Inc.、Cytomx Therapeutics, Inc.涨幅较大，Nls Pharmaceutics Ltd.、Purple Biotech Ltd、Quoin Pharmaceuticals Ltd较为活跃，换手率分别为130.68%、70.93%、57.34%，振幅较大的相关个股有Coherus Biosciences, Inc.、万春医药、Cytomx Therapeutics, Inc.，振幅分别为24.09%、14.79%、12.84%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322371798e51c09&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024120322371798e51c09&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2488608103","title":"Pharvaris N.V.盘中异动 股价大跌5.21%报20.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488608103","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488608103?lang=zh_cn&edition=full","pubTime":"2024-12-02 23:38","pubTimestamp":1733153936,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日23时38分，Pharvaris N.V.股票出现异动，股价急速下跌5.21%。截至发稿，该股报20.76美元/股，成交量3.0888万股，换手率0.06%，振幅4.33%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Senti Biosciences, Inc.、Cingulate Inc C/Wts 10/12/2026 、Neurosense Therapeutics Ltd.涨幅较大，Senti Biosciences, Inc.、Revelation Biosciences, Inc.、Cabaletta Bio, Inc.较为活跃，换手率分别为1757.72%、225.59%、24.63%，振幅较大的相关个股有Senti Biosciences, Inc.、Tc Biopharm  Plc C/Wts 10/02/2028 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为481.02%、64.17%、45.18%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233856a266bc38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202233856a266bc38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2487550044","title":"Pharvaris N.V.盘中异动 股价大跌5.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2487550044","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487550044?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:47","pubTimestamp":1732891636,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时47分，Pharvaris N.V.股票出现波动，股价快速下跌5.46%。截至发稿，该股报21.14美元/股，成交量1.0147万股，换手率0.02%，振幅5.52%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Passage Bio, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Silo Pharma, Inc.、Tc Biopharm  Plc、Applied Therapeutics, Inc.较为活跃，换手率分别为152.55%、20.69%、12.69%，振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为130.29%、41.50%、41.02%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224716971aa76c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129224716971aa76c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2486768598","title":"Pharvaris N.V.盘中异动 快速下跌5.28%报22.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486768598","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486768598?lang=zh_cn&edition=full","pubTime":"2024-11-27 23:31","pubTimestamp":1732721492,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日23时31分，Pharvaris N.V.股票出现异动，股价快速下挫5.28%。截至发稿，该股报22.89美元/股，成交量2.5643万股，换手率0.05%，振幅6.00%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为0.25%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为932.47%、85.92%、26.12%，振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Briacell Therapeutics Corp C/Wts 24/02/2025，振幅分别为66.67%、52.60%、35.46%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127233133971a8e95&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127233133971a8e95&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2486918038","title":"Pharvaris N.V.盘中异动 早盘股价大涨6.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486918038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486918038?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:34","pubTimestamp":1732545260,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时34分，Pharvaris N.V.股票出现异动，股价大幅上涨6.33%。截至发稿，该股报23.70美元/股，成交量516股，换手率0.00%，振幅0.00%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为1.09%。其相关个股中，Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.、Citius Pharmaceuticals, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为88.00%、62.49%、39.01%，振幅较大的相关个股有Foghorn Therapeutics Inc.、Anixa Biosciences, Inc.、Werewolf Therapeutics, Inc.，振幅分别为105.61%、105.47%、105.26%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223420a2548de1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223420a2548de1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2485987752","title":"Pharvaris N.V.2024财年第三财季实现净利润-45.82百万美元，同比减少78.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485987752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485987752?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291285,"startTime":"0","endTime":"0","summary":"11月23日，Pharvaris N.V.公布财报，公告显示公司2024财年第三财季净利润为-45.82百万美元，同比减少78.50%；其中营业收入为0.00美元，每股基本收益为-0.85美元。从资产负债表来看，Pharvaris N.V.总负债18.29百万美元，其中短期债务110978.90美元，资产负债比为0.20，流动比率为0.20。机构评级：截至2024年11月23日，当前有8家机构对Pharvaris N.V.目标价做出预测，其中目标均价为34.20美元，其中最低目标价为13.94美元，最高目标价为47.33美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000156abd7b8a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000156abd7b8a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS"],"gpt_icon":0},{"id":"2485326060","title":"Pharvaris N.V.盘中异动 股价大涨5.83%报22.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485326060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485326060?lang=zh_cn&edition=full","pubTime":"2024-11-22 23:42","pubTimestamp":1732290137,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日23时42分，Pharvaris N.V.股票出现波动，股价大幅拉升5.83%。截至发稿，该股报22.27美元/股，成交量1.4425万股，换手率0.03%，振幅6.87%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Replimune Group, Inc.、Exicure, Inc.、Virpax Pharmaceuticals, Inc.涨幅较大，Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为1676.82%、115.41%、82.92%，振幅较大的相关个股有Virpax Pharmaceuticals, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为62.01%、45.86%、38.10%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122234218a24e4095&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122234218a24e4095&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2485147699","title":"Pharvaris N.V.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485147699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485147699?lang=zh_cn&edition=full","pubTime":"2024-11-21 01:02","pubTimestamp":1732122168,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日01时02分，Pharvaris N.V.股票出现波动，股价大幅跳水5.17%。截至发稿，该股报19.45美元/股，成交量2.2925万股，换手率0.04%，振幅4.00%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Forte Biosciences, Inc.、Exicure, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Forte Biosciences, Inc.、Silexion Therapeutics Corp、Exicure, Inc.较为活跃，换手率分别为1506.83%、1214.35%、701.77%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Forte Biosciences, Inc.、Exicure, Inc.，振幅分别为185.64%、169.09%、136.94%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121010248971a7bc2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121010248971a7bc2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2482753249","title":"Pharvaris N.V.盘中异动 快速下挫5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482753249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482753249?lang=zh_cn&edition=full","pubTime":"2024-11-12 01:38","pubTimestamp":1731346714,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日01时38分，Pharvaris N.V.股票出现波动，股价快速跳水5.31%。截至发稿，该股报21.41美元/股，成交量1.6281万股，换手率0.03%，振幅6.10%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.30%。其相关个股中，Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 涨幅较大，Cero Therapeutics Holdings, Inc.、Revelation Biosciences, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为721.02%、496.46%、227.43%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Aligos Therapeutics, Inc.、Lakeshore Biopharma Co., Ltd，振幅分别为125.29%、72.42%、61.39%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112013834abb6bc0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112013834abb6bc0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2481935752","title":"Pharvaris N.V.盘中异动 临近午盘急速拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481935752","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481935752?lang=zh_cn&edition=full","pubTime":"2024-11-07 00:56","pubTimestamp":1730912179,"startTime":"0","endTime":"0","summary":"北京时间2024年11月07日00时56分，Pharvaris N.V.股票出现异动，股价快速拉升5.30%。截至发稿，该股报24.44美元/股，成交量1.6885万股，换手率0.03%，振幅3.23%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.51%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107005620a21d7906&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241107005620a21d7906&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2481553457","title":"Pharvaris N.V.盘中异动 下午盘股价大涨5.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481553457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481553457?lang=zh_cn&edition=full","pubTime":"2024-11-05 03:23","pubTimestamp":1730748210,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日03时23分，Pharvaris N.V.股票出现异动，股价快速上涨5.58%。截至发稿，该股报25.50美元/股，成交量6.861万股，换手率0.13%，振幅6.00%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.41%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为452.13%、284.55%、100.63%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、Ocean Biomedical Inc C/Wts 14/02/2028 、In8Bio, Inc.，振幅分别为52.25%、45.56%、45.39%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110503233098e40578&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110503233098e40578&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2479439122","title":"Pharvaris N.V.盘中异动 股价大涨5.07%报22.81美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479439122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479439122?lang=zh_cn&edition=full","pubTime":"2024-10-29 00:07","pubTimestamp":1730131672,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日00时07分，Pharvaris N.V.股票出现波动，股价快速上涨5.07%。截至发稿，该股报22.81美元/股，成交量1.6229万股，换手率0.03%，振幅5.62%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Monte Rosa Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Tc Biopharm  Plc、Genprex, Inc.、Monte Rosa Therapeutics, Inc.较为活跃，换手率分别为685.11%、102.21%、72.71%，振幅较大的相关个股有Monte Rosa Therapeutics, Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、Klotho Neurosciences Inc C/Wts 21/06/2029 ，振幅分别为95.09%、87.13%、84.14%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102900075298e3ee0d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102900075298e3ee0d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHVS"],"gpt_icon":0},{"id":"2477289374","title":"Pharvaris N.V.盘中异动 大幅拉升5.00%报22.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477289374","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477289374?lang=zh_cn&edition=full","pubTime":"2024-10-22 00:18","pubTimestamp":1729527500,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日00时18分，Pharvaris N.V.股票出现波动，股价急速上涨5.00%。截至发稿，该股报22.26美元/股，成交量1.5706万股，换手率0.03%，振幅5.99%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Genprex, Inc.、Biovie Inc.、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 涨幅较大，Genprex, Inc.、Gri Bio, Inc.、Biovie Inc.较为活跃，换手率分别为7124.81%、3308.31%、1435.03%，振幅较大的相关个股有Genprex, Inc.、Biovie Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029，振幅分别为369.73%、157.02%、148.15%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200182098e3d94e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102200182098e3d94e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2476920693","title":"Pharvaris N.V.盘中异动 股价大涨5.14%报21.89美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476920693","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476920693?lang=zh_cn&edition=full","pubTime":"2024-10-17 03:52","pubTimestamp":1729108328,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日03时52分，Pharvaris N.V.股票出现异动，股价大幅拉升5.14%。截至发稿，该股报21.89美元/股，成交量12.4391万股，换手率0.23%，振幅5.77%。Pharvaris N.V.股票所在的生物技术行业中，整体跌幅为0.09%。其相关个股中，180 Life Sciences Corp.、Proqr Therapeutics N.V.、180 Life Sciences Corp C/Wts 07/11/2025涨幅较大，180 Life Sciences Corp.、Quoin Pharmaceuticals Ltd、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为8549.13%、2094.04%、1224.83%，振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Quoin Pharmaceuticals Ltd，振幅分别为745.07%、279.52%、198.41%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017035208971a0b13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017035208971a0b13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2474017818","title":"Pharvaris N.V.盘中异动 快速上涨5.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474017818","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474017818?lang=zh_cn&edition=full","pubTime":"2024-10-12 00:58","pubTimestamp":1728665906,"startTime":"0","endTime":"0","summary":"北京时间2024年10月12日00时58分，Pharvaris N.V.股票出现异动，股价快速上涨5.72%。截至发稿，该股报18.85美元/股，成交量1.0891万股，换手率0.02%，振幅5.64%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为0.84%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Revolution Medicines Inc C/Wts 17/12/2026 、Entero Therapeutics Inc.涨幅较大，Aditxt, Inc.、Conduit Pharmaceuticals Inc.、Gritstone Bio, Inc.较为活跃，换手率分别为273.65%、269.64%、36.57%，振幅较大的相关个股有Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 ，振幅分别为171.57%、106.95%、70.00%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120058279719fba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410120058279719fba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PHVS","BK4007"],"gpt_icon":0},{"id":"2468689735","title":"Pharvaris N.V.盘中异动 下午盘股价大涨5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2468689735","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468689735?lang=zh_cn&edition=full","pubTime":"2024-09-20 02:36","pubTimestamp":1726770968,"startTime":"0","endTime":"0","summary":"北京时间2024年09月20日02时36分，Pharvaris N.V.股票出现波动，股价急速上涨5.53%。截至发稿，该股报21.38美元/股，成交量22.7465万股，换手率0.42%，振幅4.05%。Pharvaris N.V.股票所在的生物技术行业中，整体涨幅为1.14%。其相关个股中，Exicure, Inc.、Edgewise Therapeutics, Inc.、Achilles Therapeutics Plc Ads Each Repr 1 Share Spon涨幅较大，Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃，换手率分别为5392.07%、969.55%、218.01%，振幅较大的相关个股有Exicure, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 、Galmed Pharmaceuticals Ltd.，振幅分别为110.91%、88.80%、78.69%。Pharvaris N.V.公司简介：Pharvaris NV 是一家临床阶段的公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920023608ab64aad9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240920023608ab64aad9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PHVS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pharvaris.com","stockEarnings":[{"period":"1week","weight":0.0636},{"period":"1month","weight":-0.0454},{"period":"3month","weight":0.0031},{"period":"6month","weight":0.0273},{"period":"1year","weight":-0.2752},{"period":"ytd","weight":-0.3023}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Pharvaris N.V.于2015年9月30日注册在荷兰成立。他们是一家临床阶段的生物制药公司，致力于针对尚未满足需求的罕见疾病的创新疗法的开发和商业化，最初的重点是血管性水肿和其他缓激肽介导的疾病。他们的第一个分子PHA121是新型的小分子缓激肽B2受体拮抗剂，可用于治疗遗传性血管性水肿或HAE。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.020178},{"month":2,"riseRate":0,"avgChangeRate":-0.112856},{"month":3,"riseRate":0.5,"avgChangeRate":-0.050124},{"month":4,"riseRate":0.5,"avgChangeRate":0.00712},{"month":5,"riseRate":0.25,"avgChangeRate":-0.101402},{"month":6,"riseRate":0.5,"avgChangeRate":0.222248},{"month":7,"riseRate":0.25,"avgChangeRate":-0.005786},{"month":8,"riseRate":0.75,"avgChangeRate":-0.047911},{"month":9,"riseRate":0.5,"avgChangeRate":-0.05778},{"month":10,"riseRate":0.25,"avgChangeRate":-0.063186},{"month":11,"riseRate":0.25,"avgChangeRate":-0.202488},{"month":12,"riseRate":0.5,"avgChangeRate":1.208368}],"exchange":"NASDAQ","name":"Pharvaris N.V.","nameEN":"Pharvaris N.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharvaris N.V.(PHVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Pharvaris N.V.(PHVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Pharvaris N.V.,PHVS,Pharvaris N.V.股票,Pharvaris N.V.股票老虎,Pharvaris N.V.股票老虎国际,Pharvaris N.V.行情,Pharvaris N.V.股票行情,Pharvaris N.V.股价,Pharvaris N.V.股市,Pharvaris N.V.股票价格,Pharvaris N.V.股票交易,Pharvaris N.V.股票购买,Pharvaris N.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharvaris N.V.(PHVS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Pharvaris N.V.(PHVS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}